Article metrics

Download PDFPDF

1314 Trilaciclib, an intravenous cyclin-dependent kinase 4/6 inhibitor, enhances antitumor responses by modulating T cells
Free

 

Online download statistics by month:

Online download statistics by month: November 2022 to March 2024

AbstractFullPdf
Nov 2022254023
Dec 202260015
Jan 20233403
Feb 202324010
Mar 202324011
Apr 202324013
May 20231401
Jun 2023800
Jul 20232004
Aug 20231805
Sep 20231404
Oct 20232203
Nov 20231404
Dec 20233004
Jan 20241601
Feb 20242003
Mar 20241000
Total6060104